Statement re Service Provider Agreement

    For further information, please contact:

                                                          Medical Solutions plc
                                                                       Nick Ash
                                                              Managing Director
                                                             Tel: 0115 973 9010
                                                    www.medical-solutions.co.uk

                                                 Bishopsgate Communications Ltd
                                                         Nick Rome/Sophie Davis
                                                              Tel: 0207 5623350
                                              www.bishopsgatecommunications.com

                                                                 20 August 2007

                             Medical Solutions plc                             

             ("Medical Solutions" or "the Company" or "the Group")             

   Medical Solutions Geneservice chosen to be Applied Biosystems' UK service   
                    provider for SNPlex(tm) Genotyping System                     

The Board of Medical Solutions plc (LSE: MLS), the diagnostics and healthcare
business, is pleased to announce that its recently acquired genomic services
and products business Geneservice Limited has been chosen by Applied Biosystems
to be the UK service provider of its SNPlex(tm) Genotyping System and help broaden
access to its genotyping technology. Applied Biosystems is headquartered in
Foster City, California, and reported sales of over US$1.9 billion during 2006.

HIGHLIGHTS

  * Geneservice to benefit from marketing and technical support;
   
  * Geneservice was selected because of its proven proficiency in executing the
    SNPlex(tm) chemistry workflow and
   
  * SNPlex(tm) platform will enhance Geneservices' delivery of advanced genotyping
    services.
   
As part of Applied Biosystems' SNPlex(tm) Service Provider Program, Geneservice
will benefit from marketing and technical support - which is expected to
enhance its ability to deliver advanced genotyping services to its clients.
Geneservice was selected because of its proven proficiency in executing the
SNPlex(tm) chemistry workflow and generating reliable data using GeneMapper(tm)
software for data analysis.

Geneservice will use the Applied Biosystems' SNPlex(tm) technology and genotyping
and sequencing platforms to offer a system for projects needing to genotype
multiple single nucleotide polymorphisms ("SNPs") from hundreds or thousands of
samples.

The SNPlex(tm) Service Provider Program is intended to enable researchers who do
not have access to capillary electrophoresis ("CE") genetic analysis
instrumentation to obtain a flexible and bespoke high-throughput SNP genotyping
data solution.

Nick Leaves, Head of Operations for Medical Solutions said: "The SNPlex(tm)
Genotyping System is well suited to the candidate gene association studies that
typically follow whole-genome screening. We already have significant
expressions of interest in SNPlex(tm) and have completed over 900,000 custom SNP
genotypes in recent months. We are delighted to have had our experience
recognised by Applied Biosystems and to have been chosen as its partner for
this technology in the UK."

                                   --ENDS--                                    

About Medical Solutions

Medical Solutions is a fully listed UK based diagnostics and healthcare
business. Through its Healthcare operations, Medical Solutions specialises in
the provision of diagnostic and molecular pathology and cytology services and
products to the public and private healthcare sectors. It has internationally
recognised expertise in histopathology with advanced technology in image
analysis, high throughput quantitative protein expression and biomarker
determination.

Through its Diagnostic operations, including the recently acquired Geneservice
Limited, the Group offers genomic products and technology services for
applications in life sciences and clinical research and development. It offers
rapid access to high quality, leading edge genomic products essential for
manipulating gene and protein function in the majority of model organisms and
offers a one stop shop for many genomic applications. It has an international
market for its products and services and its customers include academic and
charitably funded research institutions, government laboratories and
biotechnology and pharmaceutical companies.

Geneservice offers genomic DNA extraction, quantitation, amplification, sample
re-arraying and biobanking of human DNA. Geneservice also provides "whole
genome amplification", a technology enabling the processing of minute
quantities of DNA and RNA from difficult or rare samples, which can then be
sequenced, genotyped or expression profiled. Further information is available
at http://www.geneservice.co.uk

About Applied Biosystems

Applied Biosystems is a global leader in the development and commercialization
of instrument-based systems, consumables, software, and services for the life
science market. Applied Biosystems is headquartered in Foster City, CA, and
reported sales of over US$1.9 billion during 2006. Further information about
the SNPlex(tm) Service Provider Program is available at http://
info.appliedbiosystems.com/snplex



END
Medical Solutions (LSE:MLS)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024